Reducing medicine-induced deterioration and adverse reactions (ReMInDAR) trial: study protocol for a randomised controlled trial in residential aged-care facilities assessing frailty as the primary outcome

INTRODUCTION: Many medicines have adverse effects which are difficult to detect and frequently go unrecognised. Pharmacist monitoring of changes in signs and symptoms of these adverse effects, which we describe as medicine-induced deterioration, may reduce the risk of developing frailty. The aim of...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Renly, Bereznicki, Luke, Corlis, Megan, Kalisch Ellett, Lisa M, Kang, Ai Choo, Merlin, Tracy, Parfitt, Gaynor, Pratt, Nicole L, Rowett, Debra, Torode, Stacey, Whitehouse, Joseph, Andrade, Andre Q, Bilton, Rebecca, Cousins, Justin, Kelly, Lan, Schubert, Camille, Williams, Mackenzie, Roughead, Elizabeth Ellen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Geriatric Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204916/
https://www.ncbi.nlm.nih.gov/pubmed/32327474
http://dx.doi.org/10.1136/bmjopen-2019-032851

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204916/
https://www.ncbi.nlm.nih.gov/pubmed/32327474
http://dx.doi.org/10.1136/bmjopen-2019-032851

Ejemplares similares